MedTrace Logo

Dysfunctional Attention Processes in Fear of Blushing: Specificity and Changeability

NCT00751465 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82

Last updated 2015-09-11

No results posted yet for this study

Summary

Blushing is associated with a heightened self-focused attention. In our study we are interested if this self-focused attention can be shown experimentally and if it can be changed by therapy and training. For the experimental part of the study, we want to compare blushing fearful individuals to social anxious participants who are not fearful of blushing and to healthy controls who report to blush either seldom or quite often. In the therapeutical part of our study, we compare an attention training to the standard cognitive behavioral therapy for social anxiety disorder in an intensive group therapy approach.

Conditions

  • Phobia, Social

Interventions

BEHAVIORAL

Task Concentration Training

Task Concentration Training TCT following Bögels et al. (1997).

BEHAVIORAL

Standard CBT

Standard CBT following the Clark-and-Wells (1995) model of social anxiety disorder, relying on the German manual for SAD (stangier et al., 2006). Includes the model, role-plays with and without safetey behavior, video-feedback.

Sponsors & Collaborators

  • German Research Foundation

    collaborator OTHER

  • Technische Universität Dresden

    lead OTHER

Principal Investigators

  • Jürgen Hoyer, Prof. Dr. · University of Technology Dresden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00751465 on ClinicalTrials.gov